This may be due to the fact that in metabolic disorders, SELENOP inhibits the burst of ROS required for normal insulin signaling due to the powerful reducing effect of SELENOP, so this condition is also known as reductive stress [227]. The gene discussed is INS; the disease is metabolic disease.